Abortion Pills

Medication abortion uses two FDA-approved oral medications to end a pregnancy: mifepristone and misoprostol, commonly referred to as “abortion pills.” Mifepristone interrupts the flow of the hormone progesterone that sustains the pregnancy, and misoprostol causes contractions to expel the contents of the uterus. You can use these pills in combination or use misoprostol alone.

Abortion pills are extremely safe. Serious adverse events occur in less than one-third of one percent of medication abortions. Abortion pills are over 95 percent effective when used within 10 weeks of the first day of your last menstrual period.

The organization Plan C has a comprehensive guide to finding abortion pills on their website at www.plancpills.org. Select “Find Abortion Pills” and then select the state where you are located from the drop-down menu. The website is continually updated and has all the latest information on where to find abortion pills from anywhere in the U.S.

Mifepristone Manufacturers Move to Block GOP Lawsuit Seeking Nationwide Telehealth Abortion Ban

PUBLISHED 2/11/2026 by

The attorneys general of Louisiana, Idaho and Missouri filed a lawsuit in October 2025 in a Louisiana federal court, seeking to overturn the U.S. Food and Drug Administration’s 2023 decision to allow telehealth abortion. (The Louisiana lawsuit is one of three currently active lawsuits filed by state attorneys general pushing the FDA to roll back access to mifepristone.)

Now, mifepristone’s manufacturers are moving to join the lawsuit and defend access to medication abortion.

On Feb. 3, Danco Laboratories and GenBioPro—manufacturers of the brand-name and a generic of mifepristone—filed motions to intervene, opposing Louisiana’s request for a preliminary injunction and urging the court to dismiss the lawsuit. The drugmakers argue that mifepristone has a long-established safety record—proven safe beyond any doubt by over 100 peer-reviewed studies and 25 years of real-world use by more than 7.5 million women.

GenBioPro explained its reasons for filing the motion. “We are increasingly concerned by extremists’ complete disregard for the large body of scientific evidence supporting mifepristone’s use and safety,” said GenBioPro CEO Evan Masingill. “We will not stand by while politically motivated efforts put Americans’ access to medication abortion in jeopardy.”

The next hearing in the Louisiana et al. v FDA case is set for Feb. 24, when Judge David Joseph will hear arguments on Louisiana’s preliminary injunction motion to block telehealth abortion and pharmacy dispensing of mifepristone.

Independent Clinics Still Provide Most U.S. Abortions

PUBLISHED 2/9/2026 by

2025 was a year marked by attacks on reproductive freedom, including a staggering wave of forced Planned Parenthood closures. About 50 of Planned Parenthood’s 600 locations have shut down as of December, largely due to last year’s combined loss of Title X funds and Medicaid reimbursements.

In the midst of these closures, independent abortion clinics continue to play a crucial role in the abortion access landscape. Even before last year’s Planned Parenthood cuts, independent clinics provided most U.S. abortions, offering care to women in big cities and rural healthcare deserts alike. In 2025, independent clinics provided 58 percent of U.S. abortions, compared to 38 percent through Planned Parenthood (and 3 and 1 percent through hospitals and doctors’ offices, respectively), according to the annual Communities Need Clinics report from Abortion Care Network (ACN), released in December.

Resistance, From the Red Carpet to the Courts: Grammy Winners Denounce ICE, Immigrant Families Challenge Trump’s Visa Ban

PUBLISHED 2/5/2026 by

In every issue of Ms., we track research on our progress in the fight for equality, catalogue can’t-miss quotes from feminist voices and keep tabs on the feminist movement’s many milestones. We’re Keeping Score online, too—in this biweekly roundup.

This week:
—For the first time, more Americans support than oppose abolishing ICE.
—Senate Democrats refused to pass a DHS bill that would fund ICE for this fiscal year. Instead they passed a two-week continuing resolution to give them time to negotiate reforms designed to prevent further brutality from ICE and CBP agents. 
—Artists use Grammy acceptance speeches to denounce Trump and ICE: “Our voices matter,” urged Billie Eilish. “We are humans and we are Americans,” said Bad Bunny.
—Organizations raise alarms about Grok AI spreading nonconsensual intimate images on Twitter.
—Virtual reality may be a tool to change opinions about catcalling.
—Access to IVF has led to more unmarried women in their 40s choosing to have babies.

… and more.

War on Women Report: Meta Removes Abortion-Related Accounts; Louisiana Tries to Extradite California Abortion Provider; Fatal ICE Shootings

PUBLISHED 1/30/2026 by

MAGA Republicans are back in the White House, and Project 2025 is their guide—the right-wing plan to turn back the clock on women’s rights, remove abortion access, and force women into roles as wives and mothers in the “ideal, natural family structure.” We know an empowered female electorate is essential to democracy. That’s why day after day, we stay vigilant in our goals to dismantle patriarchy at every turn. We are watching, and we refuse to go back. This is the War on Women Report.

Since our last report:
—Kentucky Attorney General Russell Coleman has tried to remove pro-abortion ads from Mayday Health, an organization that shares information about abortion pills, birth control and gender-affirming care.
—The FDA withdrew a rule requiring cosmetics companies to test their products made with talc for asbestos, alarming public health advocates.
—Two Pennsylvania hospitals told the state they may not provide emergency contraception to sexual assault survivors because of religious objections.
—Some good news out of Wyoming: The state’s supreme court started the new year by striking down Wyoming’s two abortion bans.

… and more.

Who Controls Mifepristone? The Politics Blocking a New Era of Contraception

PUBLISHED 1/22/2026 by

Mifepristone “works against endometriosis. It works against myoma [fibroids]. We are now involved in a study group that looks at whether it can prevent breast cancer,” says pioneering reproductive-health advocate Dr. Rebecca Gomperts. “It has so many potential uses, and it hasn’t been [developed].

“If we as women don’t make sure that it becomes available to meet our needs … then it won’t happen.”

This is the final installment of a new series, “The Moral Property of Women: How Antiabortion Politics Are Withholding Medical Care,” a serialized version of the Winter 2026 print feature article.

Abortion Access Can’t Depend on Rage Donations

PUBLISHED 1/21/2026 by and

Now, almost three and a half years after the Supreme Court overturned Roe v. Wade, the numbers are clear that abortion in the U.S. has, to the shock of most, continued to rise. But we also have data showing that a small but not trivial number of people are continuing their pregnancies to birth due to abortion bans. To us, what this shows is clear: that overturning Roe has prompted ingenuity, persistence, and resistance among providers and patients but is also leaving many people behind. Ultimately, this is no way to deliver healthcare.

The provision of healthcare—and abortion is healthcare—must be publicly supported in order to be equitable and accessible. When this assistance relies on inconsistent large-scale private donations, as well as the almost-supernatural work of abortion providers and supporters, it’s no wonder that some people are slipping through the cracks, even while abortion numbers are rising.

Mifepristone Could Treat Endometriosis, Some Cancers, Depression and Chronic Illness—If Politics Didn’t Interfere

PUBLISHED 1/21/2026 by

Across a range of conditions that disproportionately affect women, research into mifepristone’s potential has been slowed, defunded or blocked altogether. Nowhere is that clearer than in the treatment of endometriosis and other serious illnesses that leave millions of women in chronic pain.

Endometriosis—when endometrium cells grow outside the uterus—afflicts an estimated 10 percent of reproductive-age women. It can lead to chronic pelvic and back pain, heavy or abnormal bleeding, pain during sex or bowel movements, fatigue, bloating, digestive issues, infertility, anxiety and depression.

Mifepristone can help—it blocks the progesterone causing the cellular growth and decreases the size of existing endometrial lesions, thereby relieving painful symptoms. But antiabortion politics have obstructed the development of the medication for these uses in the U.S.

Researchers have also produced studies showing mifepristone is effective for treating ovarian and breast cancer, chronic inflammatory diseases, and several psychiatric disorders, including major depressive disorder, post-traumatic stress disorder (PTSD) and psychotic depression.

This is Part 2 of 3 in a new series, “The Moral Property of Women: How Antiabortion Politics Are Withholding Medical Care,” a serialized version of the Winter 2026 print feature article.

One Year In: 53 Ways the Second Trump Administration Is Harming Women and Families

PUBLISHED 1/20/2026 by

A sweeping, year-one rundown of how Trump’s second-term power grabs and policy rollbacks are eroding women’s rights, healthcare and economic security, including—from dismantling the Women’s Bureau at the Department of Labor and shuttering reproductive health clinics, to passing historic cuts to the Medicaid program and sowing mistrust in abortion pill safety.

‘The Moral Property of Women’: Mifepristone, Fibroids and the Stakes of Suppressed Science

PUBLISHED 1/20/2026 by

Despite mifepristone’s broad medical promise, its development has been repeatedly stymied by abortion opponents who fear wider availability would weaken their attempts to suppress abortion access.

More than 26 million women in the U.S. are affected by fibroids, which are noncancerous growths of the uterus that can reach the size of a grapefruit or larger. Treatment too often defaults to invasive surgery, either removing the fibroids or performing hysterectomies.

In China today, a three-month regimen of 10 milligrams of mifepristone per day is the approved protocol for treating fibroids. Meanwhile, American women still do not have access to this very effective nonsurgical treatment.

This is Part 1 of 3 in a new series, “The Moral Property of Women: How Antiabortion Politics Are Withholding Medical Care,” a serialized version of the Winter 2026 print feature article.

As Wisconsin Democrats Push First-Ever Pregnancy Loss Protections, State Republicans Advance Embryo ‘Personhood’

PUBLISHED 1/17/2026 by

In late 2025, Wisconsin Senate Republicans passed SB553, a bill that defines embryos, fertilized eggs and fetuses as “unborn children” and “human beings” from the moment of fertilization. The bill passed with the support of every Republican senator and opposition from all Democrats. SB 553 also attempts to redefine the word “abortion,” asserting that a termination performed to prevent the death of a pregnant woman is not an abortion if it is not “designed or intended to kill the unborn child.”

Doctors also warn that SB 553 quietly functions as a personhood law by stating that once an egg is a human being from the moment of fertilization. By granting fertilized eggs status as human beings, the bill is giving those eggs legal rights which are equal to those of their pregnant mothers. While Gov. Tony Evers has said he will veto the bill if it reaches his desk, Wisconsin state Sen. Kelda Roys says its passage reveals Republican lawmakers’ intent.

Roys recently introduced the Pregnancy Loss Protection Act, the first bill of its kind in Wisconsin. Its goal is to prevent overzealous prosecutors or law enforcement officers from targeting people who experience miscarriage or stillbirth, while also pushing back against a broader Republican effort to confer legal personhood on embryos from the moment of fertilization.